Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT01427205 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Cetuximab
DRUG: OSI-906
OTHER: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]